Skip to main content
Equibles

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Mutual Fund

Position in MYGN — Myriad Genetics Inc

CIK 1705339 CAUSEWAY BAY, K3
Back to MYGN Full portfolio

Position in MYGN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$837,051
+$339,864 QoQ
Shares Held
146,594
+32.7% QoQ
Ownership
0.153%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 196 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MYGN Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. holds $135,989,722 across 28 Diagnostics & Research names. MYGN ranks #22 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 IDXX
Idexx Laboratories Inc /De
 46,796 $24,635,285
2 TMO
Thermo Fisher Scientific Inc.
 26,909 $13,491,095
3 ILMN
Illumina, Inc.
 71,060 $12,494,478
4 DHR
Danaher Corp /De/
 52,865 $10,069,725
5 QGEN
Qiagen N.V.
 240,112 $9,388,379
6 IQV
Iqvia Holdings Inc.
 43,473 $8,399,852
7 VCYT
Veracyte, Inc.
 132,051 $7,755,354
8 NTRA
Natera, Inc.
 26,352 $7,153,249

All Filings in MYGN

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $837,051 146,594
2026-03-31 $497,187 110,486
2025-12-31 $657,877 106,972
2025-09-30 $772,387 106,831
2025-06-30 $613,687 115,572
2025-03-31 $1,688,989 190,416
2024-12-31 $2,700,883 197,001
2024-09-30 $5,174,737 188,928
2024-06-30 $5,211,569 213,065